Insights into efficacy and safety of dapagliflozin treatment for the management in older adults with type 2 diabetes: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Insights into efficacy and safety of dapagliflozin treatment for the management in older adults with type 2 diabetes: a systematic review and meta-analysis

Published:2023-01-09 Issue:5 Volume:22 Page:407-416
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Jiang Lili¹,Jia Yanyan¹,Wang Xiaoyu¹,Wang Zhe¹,Lv Xin¹,Jia Yaqin¹,Feng Yuyi¹,Yin Hang¹,Yan Mingrui¹,Fan Xiaoyu¹,Liu Yong¹

Affiliation:

1. School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin, Liaoning, China

Funder

National Key Research and Development Program of China

Fundamental Research Funds for the Central Universities

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2166485

Reference44 articles.

1. International Diabetes Federation (IDF). IDF Diabetes Atlas. In: IDF. 9th. 2019. Brussels: Belgium.

2. Disability and quality of life in elderly people with diabetes

3. Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy

4. Epidemiology of Diabetes and Diabetes Complications in the Elderly: An Emerging Public Health Burden

5. Insulin Action and Age: European Group for the Study of Insulin Resistance (EGIR)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of dapagliflozin on metabolic disorders, β islets cell function and serum protein expressions in patients with type 2 diabetes mellitus;Tropical Journal of Pharmaceutical Research;2024-04-14